Developing anticoagulation management and therapy for atrial fibrillation through primary care
284 views · Published 5 January 2015 · 2:18 · Indexed 4 November 2026
Channel: University of Birmingham · 2015 · Education
Atrial fibrillation is the commonest heart rhythm abnormality, substantially raising risk of stroke and death and affecting around 8.8 million people in the EU, with up to 2% of the UK population taking oral anticoagulation medication. Birmingham research has supported a move from lab blood tests and secondary care to primary care and more recently patient self-management through development of new testing and management approaches, which have helped improve clinical outcomes. Clinical trials led in Birmingham have also proven the safety of anticoagulation therapy in elderly patients, and led to the establishment of the National Centre for Anticoagulation Training within the University, which provides accredited training for health care professionals involved in the management of patients.
More from this channel
-
1:42:49
Interpreting Sources of the African Past: Interview with Paulo Fernando de Moreas Farias
-
2:58
Liver Disease and Liver Research: What Does the Future Offer?
-
3:34
Dr Chris Callow: Medieval Iceland
-
5:29
A creative response to A Midsummer Night's Dream by John Langdon
-
55:18
Reconfiguring race after slavery: the stories the slave-owners told
-
1:01:50
Scroll Down: Classical Jewish Texts on the Internet | University of Birmingham
-
1:12
Defining Faces: 20th Century Portrait Drawing
-
1:04
Welcome to the NIHR CLAHRC for Birmingham and Black Country